In accordance with 21 cfr 803.22 (b)(2), we are notifying you that on (b)(6) 2012, a patient reported being hospitalized on (b)(6) 2012 due to hypoglycemia.She lost consciousness and was transported to the hospital by paramedics where she received an iv.She was discharged around 12:45 a.M.On (b)(6) 2012, the patient does not know what caused this hypoglycemic event, and her basal rates have since been decreased by her healthcare professional.The cleo infusion set mentioned in this event is not manufactured by our firm.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|